Migrations
Morphotek this week announced it has appointed Robert Radie as chief business officer and promoted Luigi Grasso to senior vice president of research & development.
Radie most recently served as senior vice president of strategic projects and planning at Vicuron Pharmaceuticals. Prior to that, Radie spent his professional career in a broad range of positions at Eli Lilly. He holds a BS in chemistry from Boston College.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
